SEC Form 4 · accession 0001123292-15-000909
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Franklin M Berger
Director
Period of report
Jun 12, 2015
Accepted (ET)
Jun 16, 2015 · 5:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $22.15 | Jun 12, 2015 | A | 12,500 | A | — | Jun 11, 2025 | Common Stock | 12,500 | 12,500 | D |
Explanation of responses
- F1The option will vest in its entirety on the earlier to occur of (i) June 12, 2016 or (ii) the day before the Issuer's 2016 annual meeting of stockholders, subject to the Reporting Person's continuous service through such date.